Background/Aims: A growing body of evidence has suggested that circular RNAs (circRNAs) have crucial functions in the regulation of gene expression, and their dysregulation has been implicated in various types of cancers. However, the roles of circRNAs in laryngeal cancer remain largely unknown. This study investigated the global changes in the expression pattern of circRNAs in laryngeal squamous cell carcinoma (LSCC) to identify potential differentially expressed circRNAs. Methods: Microarray-based circRNA expression was determined in LSCC and paired normal laryngeal tissues. Pathway analyses of the genes producing differentially expressed circRNAs were performed to predict the function of circRNAs using standard enrichment computational methods. Expression levels of candidate circRNAs and microRNAs (miRNAs) were detected by quantitative real-time PCR. The circRNA/ miRNA interactions were constructed using bioinformatics methods to predict the binding of miRNA with circRNA. Results: We identified 506 differentially expressed circRNAs from human LSCC and normal laryngeal mucosa tissues. We confirmed that hsa_circ_0044520 and hsa_circ_0044529 were significantly upregulated in LSCC tissues. The most likely potential target miRNAs for hsa_ circ_0044520 and hsa_circ_0044529 were hsa-miR-4726-5p and hsa-miR-4640-5p, respectively. Functional analysis showed that hsa_circ_0044520 and hsa_circ_0044529 were involved in the process of collagen synthesis. Conclusion: Competitive endogenous RNA network prediction and bioinformatics functional analysis revealed that hsa_circ_0044520 and hsa_circ_0044529 play important regulatory roles by sponging hsa-miR-4726-5p and hsa-miR-4640-5p, thereby providing novel insights into the tumorigenesis of LSCC.
Introduction
Laryngeal cancer is one of the most common malignant neoplasms of the head and neck, accounting for 1% of cancer-related deaths worldwide [1] . A report from the National Central Cancer Registry of China stated that there were approximately 26, 400 new laryngeal cancer cases and 14, 500 deaths from laryngeal cancer in 2015, and the morbidity and mortality have been increasing in recent years [2] . Approximately 60% of patients present with advanced disease (stage III or IV) at diagnosis, and these patients can experience dysphonia, dyspnea, and dysphagia, which cause serious psychological distress and severely affect the quality of life [3, 4] . Although considerable progress has been made in surgical techniques and adjuvant chemotherapies, laryngeal cancer is unfortunately one of a few oncologic diseases in which the 5-year survival rate has decreased in the past 40 years, from 66% to 63% [5, 6] . Therefore, the identification of new biomarkers associated with the tumorigenesis of laryngeal cancer has critical significance for the early diagnosis and treatment of this disease.
Circular RNAs (circRNAs) represent a new class of abundant and stable endogenous noncoding RNAs that participate in the pathogenesis of malignant tumors [7] [8] [9] . Most known circRNA coding sequences are located in protein coding genes and thus show some general characteristics of most genes, such as conservation among species and temporal and spatial specificity of expression profiles [10, 11] . circRNAs do not form covalently closed loop structures with 5′ or 3′ polarities or polyadenylated tails, which renders them more stable than linear transcripts [12] [13] [14] . Recently, they were found to sequester microRNAs (miRNAs) by recognition of miRNA response elements (MREs). Most identified circRNAs can sequester multiple miRNAs, and thus might dysregulate the downstream miRNA-targeted transcripts in many eukaryotes [15] .
Although the biological functions of circRNAs remain to be elucidated, many reports have identified a relationship between circRNAs and oncogenesis. Expression analyses of various tumor cell lines showed widespread expression of ciRS-7 in neuroblastomas, astrocytoma and lung carcinomas [16] . Zhao et al. illustrated that clusters of circRNAs, such as hsa_circ_404833 and hsa_circ_406483, were aberrantly expressed in early stage lung adenocarcinoma [17] . Li et al. revealed that a number of circRNAs, such as hsa_circ_0001946 and hsa_circ_0005397, were dysregulated in pancreatic cancer [18] . Liu et al. identified the comprehensive expression profile of circRNAs in osteosarcoma, and confirmed that hsa_circ_103801 and hsa_circ_104980 might be involved in the initiation and progression of osteosarcoma [19] . These reported associations between circRNA expression and various cancers indicate their potential use as diagnostic biomarkers in cancer.
Despite the promising link between circRNA expression and human cancers, the role of circRNAs in laryngeal cancer remains largely unknown. We hypothesized that dysregulation of circRNAs might be involved in laryngeal tumorigenesis. Here, we used a high-throughput microarray platform to evaluate circRNA expression profiles in laryngeal squamous cell carcinoma (LSCC) and normal laryngeal mucosa from 5 LSCC patients and 5 cancer-free patients, respectively. Then, we performed step-wise bioinformatics analysis and quantitative real-time polymerase chain reaction (qRT-PCR) for validation. Our data provide a novel basis for the functional role of circRNAs in laryngeal cancer.
Materials and Methods

Ethics statement
This study was approved and supervised by The Ethics Committee of Peking Union Medical College Hospital (Beijing, China). Written informed consent was obtained from patients for research purposes. 
Patients and tissue specimens
In total, 35 patients with newly diagnosed, histopathologically confirmed and untreated LSCC were consecutively recruited at Peking Union Medical College Hospital from January 2013 to December 2015. Patients were excluded if they had a second primary tumor, metastasis, or a histopathologic diagnosis other than squamous cell carcinoma. Also, 35 cancer-free patients with laryngeal trauma who were admitted to the same hospital during the same period were recruited as controls. Pathological results were available for all individuals in both groups and the results were reviewed by an experienced pathologist. None of the patients had a previous history of cancer or had received chemotherapy or radiation therapy prior to surgery. Five LSCC cases and 5 cancer-free controls were selected for microarray assay, and the demographic and clinical characteristics are presented in Table 1 .
The excised tissue specimens were snap-frozen in liquid nitrogen immediately after resection and stored at -80ºC until RNA was extracted.
RNA extraction and quality control
Total RNA was isolated from frozen tissues in liquid nitrogen using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. RNA quantity and quality were evaluated with OD260/280 readings obtained using the Nano Drop ND-1000 spectrophotometer (NanoDrop Technologies/ Thermo Scientific, Wilmington, DE, USA) and RNA integrity was assessed by 1% formaldehyde denaturing gel electrophoresis.
RNA digestion, amplification, labeling, and hybridization
Total extracted RNA was treated with Rnase R (Epicentre, Madison, WI, USA) to remove linear RNA. Enriched circRNAs were amplified and then transcribed into fluorescent circRNAs using random primers according to the instructions for the CapitalBio cRNA Amplification and Labeling Kit (CapitalBio, Beijing, China). Amplified circRNA was purified with the RNeasy Mini Kit (Qiagen, Dusseldorf, Germany). Concentration and specific activity of the labeled circRNAs were assessed using the Nano Drop ND-1000. The labeled circRNAs were then hybridized onto the Agilent human circRNA array (version 1.0; Agilent Technologies, Santa Clara, CA, USA). The slides were rotated at 20 rpm at 42°C in an Agilent hybridization oven overnight and were then washed and scanned using the Agilent G2505C Scanner.
Microarray assay and data analysis
The Arraystar Human Circular RNA Microarray V2.0S (815k, Arraystar Inc., Rockville, MD, USA), with a total of 142, 404 circRNA probes on the microarray, was used to assess the differential expression of circRNAs in LSCC versus normal mucosa samples. Raw data were extracted from the scanned images by Agilent Feature Extraction software (version 11.0.1.1). GeneSpring software (version 13.0; Agilent Technologies) was used for the microarray data analysis, including data summarization, normalization, and quality control. The workflow was performed according to the manufacturer's instructions. Three quality control indicators were used to filter out most false signals of the microarray: 1) P < 0.001, 2) sample detection rate > 50%, and 3) fold change in expression > 2.0 between the LSCC and normal mucosa tissue samples. Interaction analysis of circRNA/miRNA was performed using Arraystar's software, which is based on miRanda and TargetScan. Cytoscape software was used for constructing the circRNA-miRNA networks. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis was performed by using the KEGG orthology-based annotation system. 
Quantitative real-time PCR (qRT-PCR)
Extracted RNA was subjected to cDNA synthesis using the SuperScript TM III Reverse Transcriptase Kit (Invitrogen), according to the manufacturer's instructions. qRT-PCR was performed using the qPCR Master Mix (Arraystar) on a ViiA 7 Real-time PCR System (Applied Biosystems) following the manufacturer's instructions. All primers used in this study are listed in Table S1 (for all supplementary material see www. karger.com/ 10.1159/000494010/). miRNA was converted to cDNA using the Stem-Loop miRNA Reverse Transcription (Ribobio, Guangzhou, China) with specific primers for hsamiR-4726-5p, hsa-miR-4640-5p, and U6 snRNA as a reference control.
Statistical analysis
Data are presented as the mean ± standard error of the mean (SEM), and were analyzed by SPSS (SPSS for Windows version 21.0; SPSS, Chicago, IL, USA). Artworks were created by using GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA). Wilcoxon matched pairs signed-rank test was used to compare the circRNA expression levels in LSCC versus normal mucosa tissues. Average cycle thresholds for the technical triplicates were calculated to yield 1 value per primer set for each biological replicate. Normalization was performed using GAPDH or U6 with the formula 2 -ΔΔCT to determine relative expression. Averages and standard deviations of the normalized biological replicate values were plotted in the figures and used in t-test calculations. P < 0.05 was considered statistically significant.
Results
Global profiling of circRNAs in LSCC tissues
We performed microarray analysis in a cohort of 5 pairs of LSCC and normal tissues, and identified a total of 82, 275 circRNAs including 3, 932 differentially expressed and 78, 343 non-differentially expressed circRNAs. After the data filtering, 506 circRNA reads were significantly differentially expressed in LSCC tissues, of which 386 were upregulated and 120 were downregulated (Table S2) . Hierarchical clustering (Fig. 1A ) and volcano plots (Fig. 1B) revealed that the expression profiles of circRNAs between LSCC and matched control normal tissues were diverse. The top 10 upregulated and downregulated circRNAs sorted by their fold change values (absolute value) are listed in Table 2 .
Pathway analysis of the genes producing differentially expressed circRNAs
To determine the pathways in which the differentially expressed circRNAs were involved, KEGG pathway analysis was performed to analyze the genes that produced them. KEGG analyses indicated that the differentially expressed circRNAs were related to the process of collagen synthesis. A total of 21 genes were identified in this pathway, of which 13 were members of the collagen family of genes (Table 3) . Disease enrichment analysis suggested that the abnormal expression of circRNAs in LSCC was associated with EhlersDanlos syndrome (a congenital connective tissue hypoplasia synthesis syndrome), which is related to collagen synthesis abnormality [20] . Fig. 2 shows the top 20 significantly enriched pathway terms and disease terms.
Candidate selection and construction of the circRNA-miRNA network circRNAs can sequester relevant miRNAs with MREs and thus post-transcriptionally regulate downstream miRNA-target genes [15] . Therefore, we used a circRNA-miRNA network strategy for candidate molecule selection. First, a miRanda-based software was used to scan the entire sequences of the selected circRNAs, after which all of the possible miRNA binding sites were recorded. The screening conditions for the circRNA-miRNA interactions were as follows: the candidate miRNA seed sequence needed to exactly match its host circRNA, and the host circRNA had to have more than 10 MREs of a single miRNA to avoid false matches. The top 20 upregulated and downregulated candidate circRNAs with the largest number of MREs were selected (Table S3 ). The top 20 target miRNAs captured by multiple circRNAs are also listed (Table S4) . Because each circRNA has multiple miRNA binding sites, and each miRNA can be captured by different circRNAs, we ranked these candidates according to circRNA coupling numbers for miRNAs and MRE number for circRNAs. These two sets of data were intersected, and the top 10 ranked upregulated and top 5 ranked downregulated candidate circRNAs were identified (Table 4) . Based on these dysregulated circRNAs and their predicted MREs, a network map of circRNA-miRNA interactions with Cytoscape was established (Fig. S1) . Interestingly, the overlapped data in the upregulated circRNAs were focused on the collagen, type 1, alpha 1 (COL1A1) gene and COL7A1 gene, which were in accordance with the results of the bioinformatics analysis. The downregulated circRNAs was focused on the LPHN2 gene and an intergenic region on chromosome 11. 
Evaluation of circRNA expression by qRT-PCR analysis
Next, we used qRT-PCR to examine the levels of the top 10 ranked upregulated and top 5 ranked downregulated candidate circRNAs that were identified above in the test cohort. None of the downregulated circRNAs in the microarray could be detected by qRT-PCR. Among the upregulated circRNAs, only hsa_circ_0044519, hsa_circ_0044520, hsa_circ_0044529, and hsa_circ_0065404 showed significantly higher expression in LSCC tissues ( Fig. 3 ; *P < 0.05, **P < 0.01). These four circRNAs were then further analyzed in an independent validation cohort with 30 LSCC patients and 30 cancer-free controls. The expression patterns of hsa_circ_0044520 and hsa_circ_0044529 were consistent with those in the test cohort ( Fig. 4 ; *P < 0.05, **P < 0.01), whereas the expression of hsa_circ_004519 and hsa_circ_0065404 showed no significant difference between the two groups (Fig. S2) . After qRT-PCR analysis,  only  hsa_circ_0044520  and  hsa_circ_0044529 showed significantly higher levels in LSCC and captured two target miRNAs on our list, hsa-miR-4726-5p and hsa-miR-4640-5p. Their expression levels were found to be significantly lower in LSCC tissues by qRT-PCR analysis in all 35 paired samples ( Fig. 5 ; ***P < 0.001). Further analysis was performed using TargetScan (http://www.targetscan.org/) for miRNA target gene scanning and DAVID (https://david.ncifcrf. gov/) for functional annotation. Interestly, we found that target genes for hsa-miR-4726-5p and hsa-miR-4640-5p were most enriched in "Tobacco Use Disorders" (Tables S5 and S6) . Discussion circRNAs are a class of endogenous noncoding RNAs with highly conserved sequences and a high degree of stability in cells. Recent studies have found that circRNAs can serve as gene regulators through a "circRNAmiRNA-mRNA" regulatory system [7] . This novel epigenetic regulatory mechanism may be crucial in physiological and pathological processes. While numerous reports have highlighted aberrant expression of circRNAs in human cancer, their expression and roles in LSCC remain to be determined.
Evaluation of the target miRNAs of hsa_circ_0044520 and hsa_circ_0044529 in LSCC
Studies on the expression of circRNAs in cancer have involved tumor tissue and adjacent normal tissue, which may not be ideal for demonstrating of the role of circRNAs in tumorigenesis, because the differentially expressed circRNAs between the tissues could result in tumorigenesis. In addition, previous studies have found aberrant gene expression in cells comprising normal adjacent tissue, which could have important implications in cancer prognosis and progression [21, 22] . Thus, in this study, normal laryngeal mucosa samples from patients with laryngeal trauma were used as controls. We performed genomewide circRNA profiling in LSCC tissues using microarray analysis and identified 3, 932 dysregulated circRNAs. By applying a set of bioinformatics tools, we found that the most upregulated expressed circRNAs were mainly associated with the collagen family genes.
To identify the most informative candidates, we designed a "circRNA-miRNA interacting network"-based strategy, based on the hypothesis that the functional dysregulated circRNAs should be potent in capturing target miRNAs. We focused on the top 10 upregulated and top 5 downregulated circRNAs. After qRT-PCR of both the discovery cohort and an independent validation cohort, hsa_circ_0044520 and hsa_circ_0044529 were found to be significantly higher expressed in LSCC tissues than in the normal controls.
circRNAs share the same sequence as their corresponding linear isomers but are formed through independent splicing mechanisms [23] . Both hsa_circ_0044520 and hsa_ circ_0044529 are hosted in the COL1A1 gene, which agrees with the result of the bioinformatics analysis. COL1A1 encodes the subunit of type I collagen, which is preferentially synthesized in the bone, dermis, and tendons [24] , and is recognized as a tumor-related gene. Previous studies reported that COL1A1 is upregulated in the tumor tissues in breast, gastric and liver cancers, and most likely participates in tumorigenesis [25] [26] [27] . Thus, the mis-splicing of COL1A1 may play a potential role in LSCC tumorigenesis.
Many studies have established a wide role for miRNAs in most biological processes and in cancer initiation and progression [28] [29] [30] . circRNAs can function as miRNA "sponges" through MREs, which naturally sequester and competitively suppress the activity of miRNAs [9, 15] . This competitive endogenous RNA network may further disturb the downstream gene expression profiles. In this study, we used bioinformative analysis to identify hsamiR-4726-5p as a target miRNA for hsa_circ_0044520, and hsa-miR-4640-5p as a target for hsa_circ_0044529. Then we evaluated the expression levels of these two miRNAs, and found that both were significantly lower in LSCC tissues than in normal control tissues. Further bioinformatics analysis revealed that target genes for hsa-miR-4726-5p and hsa-miR-4640-5p were most enriched in "Tobacco Use Disorders". This category of disorders contains numerous oncogenes related with tumorigenesis such as activating transcription factor 3, which is involved in the progression of LSCC, and as such, may provide clinical information for the evaluation of LSCC prognosis [31] . As prior studies have indicated that tobacco use is a strong risk factor for numerous cancers and shows a linear association with the development of laryngeal cancer [32, 33] , our results highlight the potential role of hsa_circ_0044520 and (Fig. 6) .
One limitation of this study was that all of the downregulated circRNAs found in microarrays were not detected by qRT-PCR analysis. It is possible that there were trace amounts of these circRNAs that were under the limit of qRT-PCR detection, and that more sensitive detection techniques are required.
Conclusion
Our study revealed the circRNA expression signatures of LSCC. Cancer-related pathways for hsa_circ_0044520 and hsa_circ_0044529 and their target miRNAs hsa-miR-4726-5p and hsa-miR-4640-5p were constructed using bioinformatics analysis. These findings suggest that dysregulation of hsa_circ_0044520 and hsa_circ_0044529 might be involved in the pathogenesis of LSCC. In the future, a larger cohort should be examined to confirm our findings and determine whether these factors can serve as novel biomarkers for LSCC diagnosis and whether their expression levels are associated with clinicopathological characteristics. In normal laryngeal mucosa cells, hsa_circ_0044520 and hsa_circ_0044529 generated from COL1A1 functioned as miRNA "sponges" to sequester and competitively suppress the activity of hsa-miR-4726-5p and hsa-miR-4640-5p. hsa-miR-4726-5p and hsa-miR-4640-5p suppressed the expression of their target RNAs, which included some oncogenes. The balance between the amount of miRNAs and their targets was well maintained. (B) In LSCC cells, the damage caused by smoking and other risk factors may disrupt the splicing pattern of COL1A1 and generate more hsa_circ_0044520 and hsa_circ_0044529. The extra circRNAs suppressed the amount of hsa-miR-4726-5p and hsa-miR-4640-5p, resulting in the upregulation of miRNA-regulated target oncogenes, and subsequent tumorigenesis. 
